Chen C C, Chang J, Chen W C
Institute of Pharmacology, College of Medicine, National Taiwan University, Taipei.
Mol Pharmacol. 1995 Jul;48(1):39-47.
Cultured astrocytes express bradykinin (BK) receptors coupled to phospholipase C (PLC)-mediated phosphoinositide (PI) hydrolysis. Short term (10- or 90-min) treatment of cells with 1 microM 12-O-tetradecanoylphorbol-13-acetate (TPA) decreased BK-induced PI breakdown, but this inhibitory action was lost after 3-hr TPA treatment. Extended (6- or 24-hr) pretreatment resulted in marked potentiation of the BK response. Western blot analysis using protein kinase C (PKC) isozyme-specific antibodies indicated that astrocytes express PKC-alpha, PKC-delta, and PKC-zeta. With TPA treatment of the cells for various times (10 min, 90 min, 3 hr, 6 hr, or 24 hr), translocation of PKC-alpha and PKC-delta from the cytosol to the membrane was seen after 10- or 90-min treatment and restoration to basal levels in the membrane fraction was seen after 3-hr treatment. However, partial or complete down-regulation of PKC-alpha and PKC-delta was seen after 6- or 24-hr treatment, respectively. No translocation or down-regulation of PKC-zeta was seen after either short term or long term TPA treatment. The inactive phorbol ester alpha-TPA had no effect on BK-induced PI hydrolysis or on the translocation or down-regulation of PKC-alpha and PKC-delta. These results suggest that, in unstimulated astrocytes, both PKC-alpha and PKC-delta, but not PKC-zeta, may exert tonic inhibition of BK-mediated PI turnover. After 10- or 90-min TPA treatment, AIF4(-)--but not Ca2+ ionophore-induced PI hydrolysis was inhibited, whereas [3H]BK binding was unaffected, indicating that the site of action of PKC-alpha and PKC-delta in the BK receptor/G protein/PLC pathway is after the receptor and before PLC, i.e., the G protein. After down-regulation of PKC-alpha and -delta, increases in both AIF4(-)-induced inositol phosphate formation and [3H]BK binding contributed to marked potentiation of BK-induced PI responses. Scatchard plot analysis showed an increase in both the maximal number of binding sites and the binding affinity. Both the up-regulation of [3H]BK binding and the subsequent BK-induced PI turnover were blocked by 0.5 microM cycloheximide, a protein synthesis inhibitor. The increase in AIF4(-)-induced PI hydrolysis after 24-hr TPA treatment was also inhibited by cycloheximide, indicating that new synthesis of BK receptors and G proteins was required after down-regulation of PKC-alpha and PKC-delta.(ABSTRACT TRUNCATED AT 400 WORDS)
培养的星形胶质细胞表达与磷脂酶C(PLC)介导的磷酸肌醇(PI)水解偶联的缓激肽(BK)受体。用1 microM 12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)对细胞进行短期(10或90分钟)处理可降低BK诱导的PI分解,但这种抑制作用在TPA处理3小时后消失。延长(6或24小时)预处理导致BK反应明显增强。使用蛋白激酶C(PKC)同工酶特异性抗体的蛋白质印迹分析表明,星形胶质细胞表达PKC - α、PKC - δ和PKC - ζ。用TPA对细胞进行不同时间(10分钟、90分钟、3小时、6小时或24小时)处理后,10或90分钟处理后可见PKC - α和PKC - δ从胞质溶胶转位到细胞膜,3小时处理后细胞膜部分恢复到基础水平。然而,6或24小时处理后分别可见PKC - α和PKC - δ部分或完全下调。短期或长期TPA处理后均未见PKC - ζ转位或下调。无活性的佛波酯α - TPA对BK诱导的PI水解或PKC - α和PKC - δ的转位或下调无影响。这些结果表明,在未受刺激的星形胶质细胞中,PKC - α和PKC - δ而非PKC - ζ可能对BK介导的PI周转发挥强直性抑制作用。10或90分钟TPA处理后,AIF4( - )诱导的而非Ca2 +离子载体诱导的PI水解受到抑制,而[3H]BK结合不受影响,表明PKC - α和PKC - δ在BK受体/G蛋白/PLC途径中的作用位点在受体之后且在PLC之前,即G蛋白。PKC - α和 - δ下调后,AIF4( - )诱导的肌醇磷酸形成和[3H]BK结合的增加导致BK诱导的PI反应明显增强。Scatchard图分析显示结合位点的最大数量和结合亲和力均增加。[3H]BK结合的上调及随后的BK诱导的PI周转均被0.5 microM环己酰亚胺(一种蛋白质合成抑制剂)阻断。24小时TPA处理后AIF4( - )诱导的PI水解增加也被环己酰亚胺抑制,表明PKC - α和PKC - δ下调后需要新合成BK受体和G蛋白。(摘要截断于400字)